Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | PAOX | Q6QHF9 | 3/20 | 0.47 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.45 |
| ▸ | MTNR1A | P48039 | 5/20 | 0.42 |
| ▸ | MTNR1B | P49286 | 5/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17457453 | 0.88 | PAOX (0.48) | KDM4EMAPK1HIF1APAOXADRA1A | |
| SCHEMBL83591 | 0.87 | KDM4E (0.42) | KDM4EMAPK1HIF1APAOXADRA1A | |
| SCHEMBL31565700 | 0.86 | KDM4E (0.48) | KDM4EMAPK1HIF1APAOXADRA1A | |
| SCHEMBL254189 | 0.84 | EPHX1 (0.46) | KDM4EMAPK1HIF1ATSHR | |
| SCHEMBL1810892 | 0.83 | EPHX1 (0.36) | KDM4EMAPK1HIF1AADRA1ATSHR | |
| SCHEMBL467687 | 0.83 | EPHX1 (0.55) | KDM4EMAPK1HIF1AMTNR1AMTNR1B | |
| SCHEMBL18180992 | 0.83 | TSHR (0.44) | KDM4EMAPK1HIF1ASMN1; SMN2TSHR | |
| SCHEMBL9322077 | 0.82 | TSHR (0.40) | KDM4EMAPK1HIF1AADRA1ASMN1; SMN2 | |
| SCHEMBL49082 | 0.81 | MTNR1A (0.37) | KDM4EMAPK1HIF1APAOXMTNR1A | |
| SCHEMBL22174072 | 0.81 | TSHR (0.52) | KDM4EL3MBTL1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 433 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12469872-B2 | Fluoropolymer hybrid composite | SYENSQO SA (BE) | 2025-11-11 | — | — | US | claimed |
| US-12391819-B2 | Fluoropolymer-based hybrid organic/inorganic composites | SYENSQO SA (BE) | 2025-08-19 | — | — | US | claimed |
| EP-3724939-B1 | FLUOROPOLYMER MEMBRANE FOR ELECTROCHEMICAL DEVICES | SYENSQO SA (BE) | 2025-08-13 | — | — | EP | claimed |
| WO-2025122886-A1 | SYSTEMS FOR SUPERELASTIC SPLINES WITH POLYMER INSULATION | ST. JUDE MEDICAL, CARDIOLOGY DIVISION, INC. (US) | 2025-06-12 | — | — | WO | claimed |
| CN-115895583-B | Under-coating-free dealcoholized single-component room temperature vulcanized silicone rubber for hydrophilic aluminum foil water-resistant adhesion and preparation method thereof | 广州集泰化工股份有限公司 | 2025-03-04 | — | — | CN | claimed |
| CN-118931455-A | Thermosensitive conductive adhesive and preparation method thereof | 苏州领冠新能源科技有限公司 | 2024-11-12 | — | — | CN | claimed |
| US-11975091-B2 | Composition for enhancing protein strength | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2024-05-07 | — | — | US | claimed |
| CN-111466042-B | Fluoropolymer membranes for electrochemical devices | 索尔维公司 | 2024-03-29 | — | — | CN | claimed |
| US-20240094630-A1 | IMPRINT COMPOSITIONS WITH PASSIVATED NANOPARTICLES AND MATERIALS AND PROCESSES FOR MAKING THE SAME | APPLIED MATERIALS, INC. | 2024-03-21 | — | — | US | claimed |
| CN-117701240-A | Organopolysiloxane composition with good shape retention and preparation method thereof | 烟台德邦科技股份有限公司 | 2024-03-15 | — | — | CN | claimed |
| WO-2016066610-A1 | POLYMER COMPRISING ALKOXYSILANE GROUPS AND USE IN COSMETICS | L'OREAL (FR) | 2016-05-06 | — | — | WO | claimed |
| US-20150253317-A1 | LABEL-FREE DETECTION OF RENAL CANCER | WASHINGTON UNIVERSITY | 2015-09-10 | — | — | US | claimed |
| WO-2015058046-A1 | PLASMONIC BIOSENSORS WITH BUILT-IN ARTIFICIAL ANTIBODIES | WASHINGTON UNIVERSITY (US) | 2015-04-23 | — | — | WO | claimed |
| EP-2580294-B1 | PVDF COATING COMPOSITIONS | SOLVAY SOLEXIS SPA (IT) | 2015-02-25 | — | — | EP | claimed |
| EP-2580294-A1 | PVDF COATING COMPOSITIONS | Solvay Solexis S.p.A. (IT) | 2013-04-17 | — | — | EP | claimed |
| US-20130090417-A1 | PVDF coating compositions | SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) | 2013-04-11 | — | — | US | claimed |
| WO-2011157657-A1 | PVDF COATING COMPOSITIONS | SOLVAY SOLEXIS S.P.A. (IT) | 2011-12-22 | — | — | WO | claimed |
| US-7921911-B2 | Surface-modifying agents for wettability modification | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2011-04-12 | — | — | US | claimed |
| WO-2010076745-A1 | SURFACE-MODIFYING AGENTS FOR WETTABILITY MODIFICATION | SCHLUMBERGER CANADA LIMITED (CA) | 2010-07-08 | — | — | WO | claimed |
| US-20100163234-A1 | Surface-Modifying Agents for Wettability Modification | SCHLUMBERGER TECHNOLOGY CORPORATION | 2010-07-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11975091-B2 | Composition for enhancing protein strength | CUTA, S100A4, S100A8 | KDM4E 437/4885MAPK1 2546/4885HIF1A 3977/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.